A closed-loop therapy for diabetic patients is proposed, by suitably exploiting a discrete Delay Dierential Equation (DDE) model of the glucose-insulin system. To this aim, plasma glucose concentration is regulated by means of subcutaneous insulin administration, in order to track a desired glucose prole. The method of exact input/output feedback linearization and stabilization is used, in order to ensure the local convergence of the tracking error to zero. The use of a state observer for delay systems makes it so that the control law requires only glucose measurements, which are easily achievable according to the present technology. Even if exogenous insulin administration is standardly used for Type I diabetic patients (who do not have a pancreatic insulin release), the use of a DDE model allows to extend the proposed treatment also to Type II diabetes. Performed simulations show the eectiveness of the proposed approach.
Palumbo, P., Pepe, P., Panunzi, S., De Gaetano, A. (2012). Observer-based glucose control via subcutaneous insulin administration. In Proceedings 8th IFAC Symposium on Biological and Medical Systems, BMS 2012; Budapest; Hungary; 29-31 August 2012 (pp.107-112) [10.3182/20120829-3-HU-2029.00065].
Observer-based glucose control via subcutaneous insulin administration
Palumbo PPrimo
;
2012
Abstract
A closed-loop therapy for diabetic patients is proposed, by suitably exploiting a discrete Delay Dierential Equation (DDE) model of the glucose-insulin system. To this aim, plasma glucose concentration is regulated by means of subcutaneous insulin administration, in order to track a desired glucose prole. The method of exact input/output feedback linearization and stabilization is used, in order to ensure the local convergence of the tracking error to zero. The use of a state observer for delay systems makes it so that the control law requires only glucose measurements, which are easily achievable according to the present technology. Even if exogenous insulin administration is standardly used for Type I diabetic patients (who do not have a pancreatic insulin release), the use of a DDE model allows to extend the proposed treatment also to Type II diabetes. Performed simulations show the eectiveness of the proposed approach.File | Dimensione | Formato | |
---|---|---|---|
2012-08 IFAC-BMS-Budapest - Glucose control via sc infusion and observer - Speaker.pdf
Solo gestori archivio
Dimensione
243.86 kB
Formato
Adobe PDF
|
243.86 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.